Antibiotic Susceptibility of Bacterial Strains Causing Asymptomatic Bacteriuria in Pregnancy: a Cross- Sectional Study in Harare, Zimbabwe

Total Page:16

File Type:pdf, Size:1020Kb

Antibiotic Susceptibility of Bacterial Strains Causing Asymptomatic Bacteriuria in Pregnancy: a Cross- Sectional Study in Harare, Zimbabwe MOJ Immunology Antibiotic Susceptibility of Bacterial Strains causing Asymptomatic Bacteriuria in Pregnancy: A Cross- Sectional Study in Harare, Zimbabwe Abstract Research Article Background and objective antibiotic susceptibility pattern: Effective among treatmentisolated bacterial of asymptomatic species among bacteriuria pregnant in Volume 6 Issue 1 - 2018 pregnancy requires susceptible drugs. The aim of this study was to determine womenMaterials with and asymptomatic Methods bacteriuria. : This study was conducted at 4 selected primary health 1Department of Nursing Science, University of Zimbabwe, care facilities in Harare, including pregnant women registering for antenatal Zimbabwe care at gestation between 6 and 22 weeks and without urinary tract infection 2Department of Medical Microbiology, University of Zimbabwe, symptoms. Asymptomatic bacteriuria was diagnosed by culture test of all Zimbabwe 3 midstream urine samples following screening by Griess nitrate test. Susceptibility Department of Obstetrics and Gynaecology, University of Zimbabwe, Zimbabwe test was done for all positive 24 hour old culture using the disk diffusion test. The resistant and intermediate. 4Institute of Clinical Medicine, University of Oslo, Norway minimum inhibitory concentration was measured and categorized as susceptible, Results *Corresponding author: : Tested antibiotics included gentamycin (88.2%), ceftriaxone (70.6%), Department of Nursing Science,Judith Mazoe Musona Street, Rukweza, PO Box nitrofurantoin (76.5%), ciprofloxacin (82.4%), ampicillin (67.6%) and norfloxacin University of Zimbabwe, College of Health Sciences, (61.8%). Prevalence of asymptomatic bacteriuria was 14.2% (95% CI, 10.28% to 19.22%). Coagulase negative staphylococcus was the most popular (29.4%) A198, Harare, Zimbabwe, Tel: 00263773917910; Email: bacteria followed by Escherichia coli (23.5%). Gentamycin (83.3%), ciprofloxacin Received: | Published: (75%) and ceftriaxone (70.8) overally had the highest sensitivity. Nitrofurantoin wasConclusion overally least sensitive (19.2%) but highly resistant (80.8%). January 04, 2018 January 23, 2018 for asymptomatic bacteriuria in pregnancy. Susceptibility test is a recommended test to guide: Drugtreatment resistance during was pregnancy. noted to be common among bacteria responsible Keywords: Asymptomatic bacteriuria; Pregnancy; Effective treatment; Antibiotic; Susceptibility test; Resistance; Susceptible; Minimum inhibitory concentration Abbreviations: ASB: Asymptomatic Bacteriuria; UTI: Urinary Tract Infection; UTIs: Urinary Tract Infections; MIC: Minimum important intervention to be implemented at primary care level Inhibitory Concentration [3,8,5]. Screening and treatment of ASB during pregnancy is an treatment decreases risk of acute urinary tract infection from Introduction [9]. Treatment of ASB in pregnancy using effective antibacterial Asymptomatic bacteriuria (ASB), a type of urinary tract national40% to 1 toguidelines 4% [3-10]. recommend All complications screening of ASB and during treatment pregnancy of infection (UTI), is one of common infections in pregnancy are reduced by antibiotic therapy [9]. Several international and available for selection for treatment of ASB in pregnancy including, more than 100 000 colony forming units per millilitre (cfu/ amoxil,ASB to reduceampicillin, risk ofcephasporin, pyelonephritis nitrofurantoin, [6]. Several antibioticstrimethoprim are ml)requiring in culture antibiotic of midstream treatment. urine ASB obtained is defined from asan growthindividual of and sulfamethoxazole [2]. Treatment of ASB with antibiotics in without signs and symptoms of asymptomatic bacteriuria [1,2]. and physiological changes occurring during pregnancy increase pregnancy aims to clear the infection, which is only possible if the ASB prevalence generally ranges from 2% to 10% [3]. Anatomic Susceptibilityisolated bacterium test informsis susceptible on effectiveness to it [6]. Selection of antibiotics of antibiotic against to treat ASB need to be based on antibiotic susceptibility results [9]. the risk of ASB [4]. When ASB is untreated in pregnancy it often infectious organisms and degree of bacterial resistance pattern pregnancyprogresses latercomplications in pregnancy and to adverse pyelonephritis, birth outcomes an acute including(UTI) [5]. Pyelonephritis is symptomatic bacteriuria associated with several selection of effective antibiotics for pathogenic strain and to prevent[11]. The prescribing test results and help administration to guide cliniciansof resistant on and appropriate ineffective UTIpre- latereclampsia, in pregnancy preterm birth,if ASB low is undetectedbirth weight and and untreated neonatal death [6,7]. Up to 40% of pregnant women develop a symptomatic antibiotics [11,12]. Results of the test are often categorized Submit Manuscript | http://medcraveonline.com MOJ Immunol 2018, 6(1): 00184 Antibiotic Susceptibility of Bacterial Strains causing Asymptomatic Bacteriuria in Copyright: 11 Pregnancy: A Cross- Sectional Study in Harare, Zimbabwe ©2018 Rukweza et al. as susceptible, resistant or intermediate depending on size of Inclusion and exclusion criteria minimum inhibition concentration (MIC) [11]. Susceptible result guaranteed to be inhibited by usual concentrations of an antibiotic Pregnant women registering and visiting sites with gestation implies that growth of the bacterial strain is likely though not between 6 and 22 weeks declaring no urinary tract infection symptoms, no clinical presentation of any infection and willing for the site of infection where the MIC is small and or equal to to participate were included in this study. Excluded were women diameter than the susceptible breakpoint [12]. Bacteria strain is who presented with urinary tract infection symptoms, those said to be resistant when the usually achievable concentrations who were unwell and who were unwilling to participate. Once of antibiotic will not inhibit growth of the isolate and treatment consent for a communication of their voluntary participation and recruited participants were required to submit their signed is highly likely to fail with MIC higher or equal than resistant another consent for permission to transport their urine to the laboratory. onbreakpoint antibiotic [11]. treatment Intermediate effect categoryand possibly means increasing response dose rate may be lower than for susceptible isolates and that there is uncertainty Urine specimen collection help to prevent ineffectiveness of drug, where MIC is between resistant and susceptible [12]. Empirical treatment, a common Mid- stream urine samples were collected in a surgically clean reportspractice, internationally is only useful andabout effective bacterial for resistancesome pathogens among with strains no enriched sanitizers to reduce risk of contamination of urine history of resistance [12]. There is presently alarmingly increasing labelled specimen bottles. Hands were cleaned with alcohol samples.Griess nitrite Perineal test area cleaning was also discouraged. causeresponsible a delay for in UTIsproper including treatment, ASB resulting [10-13]. inAntibiotic prenatal resistance mortality was known in the world since 2000 and is currently believed to and morbidity [1]. Knowledge of local sensitive and resistant All urine samples were screened for ASB using the Griess pattern of uro-pathogens is therefore required for efficacy and nitrite test, a nitrite detecting test, which assumes that almost empiricalprevention therapies of resistant before rates. sensitivity Accurate results susceptibility are out andresults even will in all bacterial species causing ASB have nitrate reductase which also help nurses and doctors with a guide on determination of aconverts laboratory nitrate in inthe a sampleMedical to Microbiologynitrite. All Griess Department positive samples of the could be promoting development of multidrug resistant bacterial were stored in a cooler box with ice packs and transported to settings where culture is unavailable. Empirical approach, which laboratory, a medical microbiologist performed culture test failure, prolonged hospital admissions and increased costs of care University of Zimbabwe. As soon as the samples arrived at the strains. These will be difficult to clear and a result in treatment bacterial colony, and antibiotic susceptibility. to confirm diagnosis, identify causative bacteria, quantify the Culture test and asymptomatic bacteriuria diagnosis Screeningand treatment of the and disease infant during or maternal antenatal deaths care is [14]. unavailable. In Zimbabwe Urine cultureASB screening and susceptibility and treatment test in is pregnancy not routinely is not done well possibly understood. due in primary health care centres possibly due to unavailability Uncentrifuged samples were incubated for 24 hours at 370C. to its high cost. Empirical treatment of UTIs is popularly practiced Bacterial growth of more than 103 cfu/ml was considered approach could be promoting development of multidrug resistant significant for ASB. Growth below 103 cfu/ml bacteria was bacterialof culture strainstest in theseresulting settings in ineffective in Zimbabwe. antibiotic Wide usetreatment. of this considered contaminated. If no growth occurred the sample was confirmedAntibiotic negative susceptibility for ASB. test required to guide treatment choice on empirical therapies for UTIS,Knowledge including of ASBantibiotic in pregnancy susceptibility in the country.patterns The is aimtherefore of this The disk diffusion test was used
Recommended publications
  • Research Article Integrating Bacterial Identification and Susceptibility
    Hindawi BioMed Research International Volume 2019, Article ID 8041746, 6 pages https://doi.org/10.1155/2019/8041746 Research Article Integrating Bacterial Identification and Susceptibility Testing: A Simple and Rapid Approach to Reduce the Turnaround Time in the Management of Blood Cultures Dariane C. Pereira1 and Luciano Z. Goldani 2 1Microbiology Unit, Laboratory Diagnosis Service, Hospital de Cl´ınicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil 2InfectiousDiseases Unit, Hospital de Cl´ınicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil Correspondence should be addressed to Luciano Z. Goldani; [email protected] Received 1 June 2019; Revised 15 August 2019; Accepted 16 September 2019; Published 3 October 2019 Academic Editor: Jiangke Yang Copyright © 2019 Dariane C. Pereira and Luciano Z. Goldani. -is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. We evaluated a rapid bacterial identification (rID) and a rapid antimicrobial susceptibility testing by disk diffusion (rAST) from positive blood culture to overcome the limitations of the conventional methods and reduce the turnaround time in bloodstream infection diagnostics. -e study included hemocultures flagged as positive by bacT/ALERT , identification by MALDI-TOF MS, and rAST. -e results were compared to identification and antimicrobial susceptibility testing (AST)® results by current standard methods, after 24 h incubation. For rAST categorical agreement (CA), very major errors (VME), major errors (ME), and minor errors (mE) were calculated. A total of 524 bacterial samples isolated from blood cultures were obtained, including 246 Gram-negative (GN) and 278 Gram-positive (GP) aerobes.
    [Show full text]
  • Investigation of Urine 2015
    UK Standards for Microbiology Investigations Investigation of Urine 2015 OCTOBER 5 - SEPTEMBER 7 BETWEEN ON CONSULTED WAS DOCUMENT THIS - DRAFT Issued by the Standards Unit, Microbiology Services, PHE Bacteriology | B 41 | Issue no: dl+ | Issue date: dd.mm.yy <tab+enter> | Page: 1 of 46 © Crown copyright 2015 Investigation of Urine Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). 2015 The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editingOCTOBER the 5 medical content. - For further information please contact us at: Standards Unit Microbiology Services Public Health England SEPTEMBER 61 Colindale Avenue 7 London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-forBETWEEN-microbiology -investigations-smi-quality- and-consistency-in-clinical-laboratories
    [Show full text]
  • Central Asian and European Surveillance of Antimicrobial Resistance
    Central Asian and European Surveillance of Antimicrobial Resistance CAESAR Manual Version 3.0 2019 Central Asian and European Surveillance of Antimicrobial Resistance CAESAR Manual Version 3, 2019 Abstract This manual is an update of the first edition published in 2015 and describes the objectives, methods and organization of the Central Asian and European Surveillance of Antimicrobial Resistance (CAESAR) network. It details steps involved for a country or area wanting to enrol in CAESAR, as well as steps involved in routine data collection for antimicrobial resistance (AMR) surveillance. It contains the protocols and AMR case definitions used by the network. Key updates involve the addition of Salmonella species to the list of pathogens under surveillance, as well as updates related to the European Committee on Antimicrobial Susceptibility Testing categories. CAESAR continues to coordinate closely with the European Antimicrobial Resistance Surveillance Network (EARS-Net) and strives for compatibility and comparability with EARS-NET, as well as the Global AMR Surveillance System coordinated by WHO headquarters. Keywords DRUG RESISTANCE, MICROBIAL ANTI-INFECTIVE AGENTS INFECTION CONTROL POPULATION SURVEILLANCE DATA COLLECTION Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional Office for Europe UN City, Marmorvej 51 DK-2100 Copenhagen Ø, Denmark Alternatively, complete an online request form for documentation, health information, or for permission to quote or translate, on the Regional Office website (http://www.euro.who.int/pubrequest). © World Health Organization 2019 All rights reserved. The Regional Office for Europe of the World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full.
    [Show full text]
  • Prevalence of Urinary Tract Infection and Antibiotic Resistance Pattern in Pregnant Women, Najran Region, Saudi Arabia
    Vol. 13(26), pp. 407-413, August, 2019 DOI: 10.5897/AJMR2019.9084 Article Number: E3F64FA61643 ISSN: 1996-0808 Copyright ©2019 Author(s) retain the copyright of this article African Journal of Microbiology Research http://www.academicjournals.org/AJMR Full Length Research Paper Prevalence of urinary tract infection and antibiotic resistance pattern in pregnant women, Najran region, Saudi Arabia Ali Mohamed Alshabi1*, Majed Saeed Alshahrani2, Saad Ahmed Alkahtani1 and Mohammad Shabib Akhtar1 1Department of Clinical Pharmacy, College of Pharmacy, Najran University, Najran, Saudi Arabia. 2Department of Obstetics and Gyneocology, Faculty of Medicine, Najran University, Najran, Saudi Arabia. Received 25 February, 2019; Accepted August 5, 2019 Urinary Tract Infection (UTI) is one of the commonest infectious disease in pregnancy, and in pregnancy we have very limited number of antibiotics to treat the UTI. This study was conducted on 151 patients who attended the gynecology clinic during the study period. Nineteen UTI proven cases of UTI were studied for prevalence of microorganism and sensitivity pattern against different antibiotics. Among the bacteria isolated, Escherichia coli (73.68%) and Staphylococcus aureus (10.52%) were the most prevalent Gram negative and Gram positive bacteria respectively. To know the resistance pattern of microorganism we used commercially available discs of different antibiotics. Gram negative bacteria showed more resistance as compared to Gram positive one. It is observed that the most effective antibiotic for Gram negative isolates is Ceftriaxone (87.5%), followed by Amoxicillin + Clavulanic acid (81.25%), Amikacin (75%), Cefuroxime (75%), Cefixime (68.75%) and Mezlocillin (62.5%). For the Gram positive bacteria, Ceftriaxone, Amikacin and Amoxicillin + Clavulanic acid were the most effective antimicrobials (100%).
    [Show full text]
  • Breaking the Cycle Asymptomatic Bacteriuria
    Breaking the Cycle Asymptomatic Bacteriuria Urinary tract infection (UTI) is the most common indication for antibiotic use in post-acute care facilities and a significant proportion of this use is inappropriate and unnecessary. Asymptomatic bacteriuria (ASB) is prevalent in residents of post-acute care facilities and is frequently misidentified as a “UTI”. www.preventHAIaz.gov For comments or question please contact: [email protected] Definitions: ASB refers to bacteria in the urine at levels often regarded as clinically significant (>100,000 colonies/ml) but with no symptoms or localizing signs suggestive of UTI. Pyuria (>10 WBC/ hpf) accompanying ASB is not an indication for antibiotic treatment. Ordering of UA/C&S: The ‘Choosing Wisely’ guideline from the American Medical Directors Association (AMDA) recommends against obtaining urine studies unless there are clear signs and symptoms that localize to the urinary tract. Multiple studies have also shown that confusion or altered mental status is not a reliable indication for urine studies. Such studies often lead to unnecessary antibiotic treatment. Urine studies are not recommended for: • Change in urine color, odor or turbidity – these are typically due to resident hydration and not indicators of infection • Catheterized residents while the catheter remains in situ. This includes both Foley and suprapubic catheters • After a patient fall Common ways ASB masquerades as an infection requiring antibiotic treatment: requiring antibiotic as an infection ASB masquerades Common ways • To document
    [Show full text]
  • (IQC) Antimicrobial Susceptibility Tests Using Disk Diffusion
    Internal Quality Control (IQC) Antimicrobial Susceptibility Tests Using Disk Diffusion National AMR Surveillance Network, NCDC National Programme on Containment of Antimicrobial Resistance National Centre for Disease Control, New Delhi April 2019 CONTENTS I. Scope .......................................................................................................................................................... 2 II. Selection of Strains for Quality Control ..................................................................................................... 2 III. Maintenance and Testing of QC Strains..................................................................................................... 3 Figure 1: Flow Chart: Maintenance of QC strains in a bacteriology lab......................................................... 4 IV. Quality Control (QC) Results—Documentation - Zone Diameter ............................................................. 5 V. QC Conversion Plan ................................................................................................................................... 5 1. The 20- or 30-Day Plan .......................................................................................................................... 5 2. The 15-Replicate (3× 5 Day) Plan ......................................................................................................... 5 3. Implementing Weekly Quality Control Testing ..................................................................................... 6 4.
    [Show full text]
  • UTI) Using Urinary Nitrite and Significant Bacteriuria (SBU
    Available online at www.ijmrhs.com International Journal of Medical Research & ISSN No: 2319-5886 Health Sciences, 2016, 5, 4:6-15 Comparative diagnosis of urinary tract infection (UTI) using urinary nitrite and significant bacteriuria (SBU) 1John Anuli S., 2Mboto Clement I. and *2Agbo Bassey E. 1Department of General Studies, College of Health Technology, Calabar, Nigeria 2Department of Microbiology, Faculty of Biological Sciences, University of Calabar,P.M.B. 1115, Calabar, Nigeria *Corresponding Authors E-mail: [email protected] _____________________________________________________________________________________________ ABSTRACT The clinical laboratory diagnosis of urinary tract infection was compared in two hundred (200) midstream urine samples using bacteria culture and urinary nitrite detection technique. The comparative susceptibility of the isolates to common antibiotics was evaluated using completely randomized design (CRD). The minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) for each antibiotics test was evaluated using standard laboratory procedures. Approximately fifty one percent (101/200) of urine samples that were culture yielded significant bacteriuria (SBU) as compared to (32.59%, 65/200) which had positive nitrite detection. Also eighteen percent (18%, 35/200) of the negative nitrite detection test showed evidence of significant bacteriuria. Significant bacteriuria was significantly associated at p <0.05 with culture isolation technique. A total of nine (9) different bacterial isolates were detected in this study. The isolates and their frequency of occurrence were Escherichia coli 30(29.7%), Pseudomonas aeruginosa 15(14.9%), Klebsiella pneumonia 13(12.8%), Enterococcus faecalis and Citrobacterfreundii 10(9.9), Proteus mirabilis 9(8.9), Staphylococcus aureus 8(7.7%), Serretiamarcesens and Streptococcus specie 3(3.0%).The mean total viable count ranged from 31.50±3.15x10 7cfuml -1 to 262.5±1.09x10 8cfuml -1.
    [Show full text]
  • Method for the Detection of Significant Bacteriuria in Large Groups of Patients
    J Clin Pathol: first published as 10.1136/jcp.17.5.498 on 1 September 1964. Downloaded from J. clin. Path. (1964), 17, 498 Method for the detection of significant bacteriuria in large groups of patients D. A. LEIGH AND J. D. WILLIAMS From the Department of Pathology, Edgware General Hospital SYNOPSIS A measured area of blotting paper was used as a vehicle for transferring a constant aliquot of urine on to the surface of a culture medium. The number of bacterial colonies growing in the inoculum area of the medium corresponded to the number of organisms in the urine. One thousand, two hundred and seventy-five urines from women attending an ante-natal clinic were tested by this method, and the results compared with the results of quantitative bacterial counting and of triphenyl tetrazolium chloride (T.T.C.) tests. The method was found to be a simple, cheap, and reliable way of screening urine specimens for significant bacteriuria. The increased incidence of urinary tract infection, METHODS often persisting asymptomatically, which has been found in certain sections of the population, notably THE PAPER STRIP A Postlip Mill 633 fibre-free, fluffless pregnant women (Kaitz and Hodder, 1961; Monzon, paper supplied to the laboratory for use as blotting paper was used for the paper strips. Strips were cut 3 in. long Armstrong, Pion, Deigh, and Hewitt, 1963), has led by i in. wide and a fold was made across the strip i copyright. in. to a search for screening tests which are simple to from one end (Fig. 1). The X in.
    [Show full text]
  • A Ketoconazole Susceptibility Test for Malassezia Pachydermatis Using Modified Leeming–Notman Agar
    Journal of Fungi Article A Ketoconazole Susceptibility Test for Malassezia pachydermatis Using Modified Leeming–Notman Agar Bo-Young Hsieh 1,2, Wei-Hsun Chao 3, Yi-Jing Xue 2 and Jyh-Mirn Lai 2,* 1 Lugu Township Administration, Nanto County 55844, Taiwan; [email protected] 2 College of Veterinary Medicine, National Chiayi University, No. 580, XinMin Rd., Chiayi City 60054, Taiwan; [email protected] 3 Department of Hospitality Management, WuFung University, Chiayi City 60054, Taiwan; [email protected] * Correspondence: [email protected]; Tel.: +886-5-2732920; Fax: +886-5-2732917 Received: 18 September 2018; Accepted: 14 November 2018; Published: 16 November 2018 Abstract: The aim of this study was to establish a ketoconazole susceptibility test for Malassezia pachydermatis using modified Leeming–Notman agar (mLNA). The susceptibilities of 33 M. pachydermatis isolates obtained by modified CLSI M27-A3 method were compared with the results by disk diffusion method, which used different concentrations of ketoconazole on 6 mm diameter paper disks. Results showed that 93.9% (31/33) of the minimum inhibitory concentration (MIC) values obtained from both methods were similar (consistent with two methods within 2 dilutions). M. pachydermatis BCRC 21676 and Candida parapsilosis ATCC 22019 were used to verify the results obtained from the disk diffusion and modified CLSI M27-A3 tests, and they were found to be consistent. Therefore, the current study concludes that this new novel test—using different concentrations of reagents on cartridge disks to detect MIC values against ketoconazole—can be a cost-effective, time-efficient, and less technically demanding alternative to existing methods.
    [Show full text]
  • Rapid Identification and Antimicrobial Susceptibility Testing of Positive
    Rapid identification and antimicrobial susceptibility testing of positive blood cultures using MALDI-TOF MS and a modification of the standardised disc diffusion test: a pilot study. Item Type Article Authors Fitzgerald, C;Stapleton, P;Phelan, E;Mulhare, P;Carey, B;Hickey, M;Lynch, B;Doyle, M Citation Rapid identification and antimicrobial susceptibility testing of positive blood cultures using MALDI-TOF MS and a modification of the standardised disc diffusion test: a pilot study. 2016 J. Clin. Pathol. DOI 10.1136/jclinpath-2015-203436 Publisher BMJ Journal Journal of clinical pathology Rights Archived with thanks to Journal of clinical pathology Download date 26/09/2021 22:03:45 Link to Item http://hdl.handle.net/10147/620889 Find this and similar works at - http://www.lenus.ie/hse Rapid Identification and Antimicrobial Susceptibility testing of Positive Blood Cultures using MALDI-TOF MS and a modification of the standardized disk diffusion test - a pilot study. Fitzgerald C1, Stapleton P1, Phelan E1 , Mulhare P1, Carey B1, Hickey M1, Lynch B1, Doyle M1. 1Microbiology Laboratory, University Hospital Waterford, Dunmore road, Waterford, Ireland Corresponding author: [email protected] Telephone: 00353-51-842488 Fax: 00353-51-848566 1 Keywords: blood culture, MALDI-TOF MS, rapid identification, rapid antimicrobial susceptibility testing, disk diffusion, clinical impact Word count: 3,000 Abstract Aims In an era when clinical microbiology laboratories are under increasing financial pressure, there is a need for inexpensive, yet effective, rapid microbiology tests. The aim of this study was to evaluate a novel modification of standard methodology for the identification and antimicrobial susceptibility testing (AST) of pathogens in positive blood cultures, reducing the turnaround time of laboratory results by 24 hours Methods 277 positive blood cultures had a gram stain performed, were o subcultured and incubated at 37 C in a CO2 atmosphere for 4 to 6 hours.
    [Show full text]
  • 1815-IJBCS-Article-Sylvester Okorondu
    Available online at http://ajol.info/index.php/ijbcs Int. J. Biol. Chem. Sci. 7(4): 1668-1677, August 2013 ISSN 1991-8631 Original Paper http://indexmedicus.afro.who.int Prevalence and antibiotic sensitivity profile of urinary tract infection pathogens among pregnant and non pregnant women S. I. OKORONDU 1* , C. O. AKUJOBI 1, C. B. NNADI 1, S. O. ANYADO-NWADIKE 2 et M. M. O. OKORONDU 3 1Department of Microbiology, Federal University of Technology Owerri, P.M.B. 1526, Owerri, Nigeria. 2Department of Biotechnology, Federal University of Technology Owerri, P.M.B. 1526, Owerri, Nigeria. 3Department of Biochemistry, Federal University of Technology Owerri, P.M.B. 1526, Owerri, Nigeria. * Corresponding author; E-mail: [email protected] ABSTRACT The prevalence and antibiotic sensitivity profile of urinary tract infection isolates from 100 pregnant women attending antenatal clinic in Owerri General Hospital, Nigeria was assessed. The prevalence of UTI isolates from the pregnant women was compared with that in non-pregnant women. The organisms isolated include: Escherichia coli, Staphylococcus aureus , Coagulase negative Staphylococcus, Klebsiella spp , Pseudomonas spp, Proteus spp and Streptococcus spp. Antibiotic sensitivity pattern of the isolates were also determined using disk diffusion test. One hundred (100) women were tested; 40% had bacteriuria as against 31% in non-pregnant women. The most sensitive isolate was E. coli, while the least was Streptococcus spp. The most effective antibiotics were Gentamycin, Tarivid and Ciprofloxacin, while the least occurred with Chloramphenicol, Ampicillin, Septrin, Ampiclox. Improvement on personal hygiene and diagnostic screening and treatment will help to reduce the prevalence of bacteriuria in pregnancy.
    [Show full text]
  • Asymptomatic Bacteriuria in Adults RICHARD COLGAN, M.D, University of Maryland School of Medicine, Baltimore, Maryland LINDSAY E
    Asymptomatic Bacteriuria in Adults RICHARD COLGAN, M.D, University of Maryland School of Medicine, Baltimore, Maryland LINDSAY E. NICOLLE, M.D., University of Manitoba, Winnipeg, Canada ANDREW MCGLONE, M.D., University of Maryland School of Medicine, Baltimore, Maryland THOMAS M. HOOTON, M.D., University of Washington School of Medicine, Seattle, Washington A common dilemma in clinical medicine is whether to treat asymp- tomatic patients who present with bacteria in their urine. There are few scenarios in which antibiotic treatment of asymptomatic bacter- uria has been shown to improve patient outcomes. Because of increas- ing antimicrobial resistance, it is important not to treat patients with asymptomatic bacteriuria unless there is evidence of potential ben- efit. Women who are pregnant should be screened for asymptomatic bacteriuria in the first trimester and treated, if positive. Treating asymptomatic bacteriuria in patients with diabetes, older persons, patients with or without indwelling catheters, or patients with spinal cord injuries has not been found to improve outcomes. (Am Fam Physician 2006;74:985-90. Copyright © 2006 American Academy of Family Physicians.) rinary tract infections (UTIs) with asymptomatic bacteriuria will be influ- are one of the most common enced by patient variables: healthy persons infections for which antibiotics will likely have E. coli, whereas a nursing are prescribed. The Infectious home resident with a catheter is more likely to UDiseases Society of America (IDSA) issued have multi-drug–resistant polymicrobic flora guidelines for the treatment of uncomplicated (e.g., P. aeruginosa). Enterococcus species and acute bacterial cystitis and acute pyelonephri- gram-negative bacilli are common in men.9,10 tis in women.1 The presence of bacteria in the urine of an asymptomatic patient is known Diagnosis as asymptomatic bacteriuria.
    [Show full text]